Azenta, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AZTA | BLFS | RGEN | AVTR | NNNN | BNGO | |
|---|---|---|---|---|---|---|
| Market cap | 1.65B | 1.89B | 10.95B | 10.48B | 193.56M | 15.84M |
| P/E (TTM) | — | 39.0 | 233.1 | — | 27.6 | — |
| Forward P/E | 68.4 | 117.0 | 65.3 | 17.7 | — | -1.4 |
| Price/book | 1.1 | 4.5 | 4.6 | 1.9 | 6.4 | 0.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +23.43% | +39.59% | +16.25% | +11.36% | −84.29% | −35.41% |
| Today | +0.13% | 0.00% | −0.79% | −1.15% | −5.36% | −6.27% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All AZTA news ›Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 12, 2026 13:15 ET | Source: The Rosen Law Firm PA The Rosen Law Firm PA NEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on…
Azenta (NASDAQ:AZTA) Upgraded to “Buy” at Wall Street Zen
Posted by Mitch Edgeman on Oct 11th, 2026 Wall Street Zen upgraded shares of Azenta (NASDAQ:AZTA – Free Report) from a hold rating to a buy rating in a report published on Saturday,Wall Street Zen reports. Read Our Latest Report on Azenta…
Azenta (NASDAQ: AZTA) approves Multiomics restructuring, targets $11 million in savings
Posted by Kim Johansen on Oct 10th, 2026 Azenta, Inc. (NASDAQ: AZTA) said on October 5, 2026, that its board approved a restructuring plan in the Multiomics segment. The plan includes workforce reductions and the closure of three…
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Oct 10, 2026, 12:14 ET NEW YORK, Oct. 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting…
Azenta formalizes interim CEO pay and retention grants
Azenta ( (AZTA) ) has issued an update. The most recent analyst rating on (AZTA) stock is a Buy with a $37.00 price target. To see the full list of analyst forecasts on Azenta stock, see the AZTA Stock Forecast page. Spark’s Take on AZTA…
Azenta shutting three Multiomics lab sites under restructuring plan
Azenta (AZTA) stock gains as the company announces a restructuring plan that involves closure of three North America Multiomics lab sites and layoffs. Read more here. Azenta (AZTA) on Wednesday announced plans to close three lab sites…
Azenta Inc (AZTA) Shares Fall 7.9% -- What GF Score of 83 Tells Investors
On October 06, 2026, Azenta Inc AZTA shares fell 7.9% today, currently priced at $39.35. This move comes amid a 52-week range of $15.93 to $46.41, reflecting significant volatility over the past year. Given the current circumstances, the…
Azenta Inc (AZTA) Shares Surge 12.4% -- What GF Score of 79 Tell
On October 02, 2026, Azenta Inc AZTA shares rose 12.4%, bringing the current price to $38.75. This price movement occurs within a 52-week trading range of $15.93 to $42.00, reflecting significant volatility and recent upward momentum.…
Cleanroom Equipment Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA • Azenta Life Sciences
openPR.com Cleanroom Equipment Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA • Azenta Life Sciences Press release from: WMR Permanent link to this press release: You can edit or delete your press release Cleanroom…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
globenewswire.com3
-
gurufocus.com2
-
themarketsdaily.com2
-
tigersroar.com2
-
newsfilecorp.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.